Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. It has not gone away. Instead, the challenges of AMR now need to be seen through the lens of changing clinical care due to COVID-19.
Here we list some of the online resources, opinions pieces and publications available on this topic, compiled by Gwen Knight. For more insights from Gwen on this subject, read her article Thinking about AMR again?
Online databases
- Issra Bulgasim & Adam Roberts at the Liverpool School for Tropical Medicine have compiled on secondary infections, antibiotic chemotherapy and antibiotic resistance in the context of COVID-19.
- The British Society for Antimicrobial Chemotherapy and JAC-Antimicrobial Resistance have developed a committed to “signposting vital information and latest guidance from health bodies, academic publications and other professional societies”.
Literature
- .
Gwenan M Knight, Rebecca E Glover, C Finn McQuaid et al. eLife 2021; 10:e64139.
- Opinion pieces from key AMR organisations: , , , , , , CARB-X.
Cornelius J Clancy, MD, M Hong Nguyen, MD Clinical Infectious Diseases, ciaa524. 01 May 2020
Aimee K Murray. Opinion Article Frontiers in Microbiology. 13 May 2020.
BMJ 2020; 369. 18 May 2020
Timothy M Rawson, Luke S P Moore, Enrique Castro-Sanchez, Esmita Charani, Frances Davies, Giovanni Satta, Matthew J Ellington, Alison H Holmes. Journal of Antimicrobial Chemotherapy, dkaa194. 20 May 202
Editorial: Nature Microbiology. 5, 779. 20 May 2020
- .
JAC - Antimicrobial Resistance. Volume 2, issue 3.